Axial Microbiome Webinar
Register now for a complimentary webinar with Sarkis Mazmanian, PhD, Prof. of Microbiology at Caltech and David Donabedian, PhD, Co-Founder and CEO of Axial Biotherapeutics. This is an exclusive webinar for Microbiome Gut-Brain Axis Summit organised in order to discuss the recent phenomena of the gut-brain axis and the scientific advances getting researchers close to a new class of therapeutics to treat neurological disease.
Participants will also have the chance to ask questions live, during the course of the webinar.*
Title: Harnessing the gut microbiome to treat neurological diseases
Duration: 60 mins
Date: Wednesday, October 18, 2017
Time: 7:00pm – 8:00pm Central European Time/12:00 pm – 1:00 pm EST
Registration link: https://register.gotowebinar.com/register/694348575369795586
Harnessing the gut microbiome to treat neurological diseases
Rapidly emerging research data suggests that there is a link between changes in the gut microbiome and neurological diseases and disorders. This webinar will outline scientific advances in unraveling the gut-brain connections and potential pathways to harness these findings for novel therapeutic approaches.
Join two co-founders of a leading microbiome-focused biotech company to:
• Learn what we know about the connection between gut microbiota and the brain, recent advances in CNS disease progression linking and how these findings have created a new paradigm of how we think about neurological diseases
• Probe data and experience from the broader microbiome space and the translational attempts in other therapeutic indications
• Discuss the path forward and critical steps towards developing a new class of therapeutics
*Moderator will review and keep relevant questions to ask Sarkis and David.